Unaltered mRNA expression of CD46, CD55, and CD59 with their differential surface protein expression (lower expression for CD46 and CD55, and higher expression for CD59) in CAD patients may perhaps be due to alterations in regulation at the steps of protein translation or post-translational modifications, although it remains to be addressed in detail. This evidence concerns the gene CD46 and coronary artery disorder.